Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy. - Concepedia

Concepedia

Publication | Closed Access

Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy.

30

Citations

0

References

2011

Year

Dennis Eurich, Marcus Bahra, Thomas Berg, Sabine Boas‐Knoop, Michael Biermer, R. Neuhaus, P. Neuhaus, Ulf Neumann

Abstract

Intravenous silibinin is an effective therapeutic approach for treating hepatitis C-virus-reinfection after liver transplant and should be evaluated further.